Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2020
Pharma News, 2020
Gilead to Acquire Forty Seven for $4.9 Billion
FOSTER CITY, Calif.
GlaxoSmithKline reportedly looking to sell select antibiotic brands
Sale would fund R&D efforts in other key focus areas such as oncology.
BIOGEN and SANGAMO announced global licensing collaboration agreement
CAMBRIDGE, Mass.
Merck and AMCM / EOS Cooperate in 3D Printing of Tablets
Merck, a leading science and technology company and AMCM, Starnberg, Germany, today announced a cooperation agreement on the 3D printing of tablets.
FUJIFILM Diosynth Biotechnologies expands North Carolina Facility
MORRISVILLE, N.
Takeda Acquires PvP Biologics Following Results of a Phase 1 Study of TAK-062 (Kuma062) for the Treatment of Celiac Disease
Osaka, Japan, February 26, 2020–Takeda Pharmaceutical Company Limited (TSE.
STADA becomes a major Consumer Healthcare player by acquiring 15 well-established GSK brands
Bad Vilbel, February 24, 2020 – STADA AG is significantly expanding its global OTC business agreeing to acquire a portfolio of well-established local and regional consumer healthcare brands from Gla...
U.S. Health Secretary Says at Least 40 Labs Can Currently Test for Coronavirus
U.
New study allows Brain and Artificial Neurons to link up over the web
Research on novel nanoelectronics devices led by the University of Southampton has enabled brain neurons and artificial neurons to communicate with each other.
Gilead starts two late-stage studies to test drug for coronavirus
(Reuters) - Gilead Sciences Inc (GILD.
Chinese heparin maker tried to sneak proof of its unapproved APIs out the back door
On arrival for a pre-approval inspection for a Chinese heparin API maker, an FDA inspector was told that the plant had not started making products and was only doing equipment testing.
FDA approves first generic of ProAir HFA
The U.
59
60
61
62
63
64
65
66
67
